簡(jiǎn)體中文Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved
Release time：2021-12-12
Our new formulation L-Ornithine-L-Aspartate Infusion for injection( 5gm/10ml ) has been approved by China SFDA on 23th April 2020. The injection registration certificate No. is H20203173.
Reprint statement: reprint please indicate "source: Wista pharma".
Back
Luliconazole and posaconazole are launched into market
86-10-67887855
Head Office：
Marketing：
Wista Pharmam